Marco Colleoni Selected Research

Letrozole (Femara)

2/2021	Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
1/2021	Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
3/2020	Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
10/2019	Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
10/2019	Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.
1/2019	Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
1/2019	A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
1/2019	Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
1/2019	Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
10/2018	Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Colleoni Research Topics

Disease

169	Breast Neoplasms (Breast Cancer) 03/2022 - 09/2002
75	Neoplasms (Cancer) 01/2022 - 12/2003
15	Triple Negative Breast Neoplasms 04/2022 - 09/2008
8	Neutropenia 01/2021 - 04/2016
6	Disease Progression 04/2022 - 03/2004
5	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2002
4	Lobular Carcinoma 10/2021 - 10/2009
4	Infections 01/2021 - 01/2018
4	Hypertension (High Blood Pressure) 01/2018 - 12/2007
4	Ductal Carcinoma 09/2015 - 07/2009
3	Febrile Neutropenia 01/2021 - 10/2016
3	Heart Failure 01/2020 - 02/2007
3	Inflammatory Breast Neoplasms 01/2018 - 09/2008
3	Arthralgia (Joint Pain) 01/2018 - 02/2007
3	Hypercholesterolemia 04/2017 - 02/2007
2	Alopecia (Baldness) 12/2021 - 01/2019
2	Residual Neoplasm 10/2021 - 03/2011
2	Fatigue 12/2020 - 01/2020
2	Nausea 12/2020 - 07/2018
2	Cardiotoxicity 01/2020 - 12/2010
2	Pathologic Complete Response 12/2019 - 08/2014
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Hot Flashes 11/2016 - 02/2007
2	Lymphatic Metastasis 08/2014 - 10/2010
2	Bone Fractures (Bone Fracture) 04/2008 - 02/2007
2	Venous Thromboembolism 10/2007 - 10/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021

Drug/Important Bio-Agent (IBA)

67	Hormones (Hormone)IBA 04/2022 - 10/2004
33	Tamoxifen FDA LinkGeneric 01/2022 - 03/2006
27	Estrogen ReceptorsIBA 10/2021 - 10/2004
26	Letrozole (Femara)FDA LinkGeneric 02/2021 - 02/2007
19	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 06/2004
18	Phenobarbital (Luminal)FDA Link 12/2021 - 04/2012
17	Biological ProductsIBA 04/2022 - 06/2004
17	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2008
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2018 - 03/2004
15	palbociclibIBA 01/2022 - 04/2016
14	Aromatase InhibitorsIBA 02/2021 - 12/2007
13	Trastuzumab (Herceptin)FDA Link 01/2022 - 09/2006
11	human ERBB2 proteinIBA 01/2021 - 06/2010
11	exemestane (Aromasin)FDA Link 12/2020 - 07/2014
11	Fluorouracil (Carac)FDA LinkGeneric 08/2015 - 09/2005
10	Estrogens (Estrogen)FDA Link 01/2022 - 06/2004
10	Fulvestrant (Faslodex)FDA Link 01/2022 - 09/2012
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
9	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 09/2002
9	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 11/2006
8	Capecitabine (Xeloda)FDA Link 10/2021 - 10/2008
7	SteroidsIBA 08/2013 - 10/2004
6	AnthracyclinesIBA 12/2021 - 05/2008
6	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2008
6	Epirubicin (Ellence)FDA LinkGeneric 08/2015 - 11/2006
5	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 12/2010
5	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021 - 12/2008
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 09/2008
5	Progesterone FDA LinkGeneric 01/2018 - 09/2008
4	ribociclibIBA 03/2022 - 01/2018
4	pertuzumabIBA 01/2022 - 01/2018
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 12/2003
3	Cyclin-Dependent Kinase 4IBA 01/2022 - 11/2018
3	taxaneIBA 10/2021 - 01/2008
3	Triptorelin Pamoate (Trelstar)FDA Link 10/2019 - 04/2010
3	ParaffinIBA 01/2019 - 07/2012
3	Formaldehyde (Formol)FDA Link 01/2019 - 07/2012
3	Pharmaceutical PreparationsIBA 10/2016 - 02/2010
3	Alkylating AgentsIBA 08/2014 - 06/2010
3	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 06/2010
3	1-dodecylpyridoxal (PLD)IBA 04/2013 - 12/2010
2	Gemcitabine FDA Link 10/2021 - 09/2008
2	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 03/2016
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2019
2	MethyltransferasesIBA 08/2014 - 07/2012
2	Hemoglobins (Hemoglobin)IBA 06/2012 - 01/2008
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2012 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010 - 01/2009
2	Leucovorin (Folinic Acid)FDA Link 12/2008 - 09/2002
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2004 - 09/2002
1	Thymidine KinaseIBA 01/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2022
1	sperm releasing substanceIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	eribulin FDA Link 10/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	niraparibIBA 10/2021
1	Circulating Tumor DNAIBA 01/2021
1	tucatinibIBA 01/2021

Therapy/Procedure

83	Therapeutics 03/2022 - 01/2003
63	Drug Therapy (Chemotherapy) 01/2022 - 09/2002
17	Adjuvant Chemotherapy 12/2021 - 04/2003
14	Neoadjuvant Therapy 10/2021 - 02/2008
6	Radiotherapy 12/2020 - 10/2010
6	Mastectomy (Mammectomy) 01/2018 - 10/2010
3	Catheters 10/2007 - 10/2005
2	Drug Tapering 12/2020 - 10/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 10/2011
2	Segmental Mastectomy (Lumpectomy) 10/2016 - 11/2012